Denmark· DK-28106027617
GHRYVELIN
A macimorelin product containing macimorelinacetat, registered in Denmark by Atnahs Pharma Netherlands B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Macimorelin is registered in 12 of 19 countries.
Countries holding a registration under ATC V04CD06 (macimorelin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Macimorelin · ATC V04CD06
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Macimorelinacetat
- Manufacturer
- Atnahs Pharma Netherlands B.V.
- Country
- Denmark (DK)
- ATC code
- V04CD06
- ATC class
- Macimorelin
- Defined daily dose
- 35 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106027617
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
398 interactions on record for macimorelin.
Graded by severity as the source publishes them — 241 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Macimorelin · interactions on record
398 records
- 241 severe
- 154 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V04CD06
Macimorelin, as other registers publish it.
- NorwayGhryvelinAtnahs Pharma Netherlands B.V.
- CzechiaGHRYVELINAtnahs Pharma Netherlands B.V., Amsterdam
- FinlandGHRYVELINAtnahs Pharma Netherlands B.V.
- IcelandGHRYVELINAtnahs Pharma Netherlands B.V.
- PolandGHRYVELINAtnahs Pharma Netherlands B.V.
- BelgiumGhryvelin 60 mgAtnahs Pharma Netherlands
- NetherlandsGHRYVELIN 60 mg granulaat voor orale suspensie in sachetAtnahs Pharma Netherlands B.V.
- IrelandGHRYVELIN 60 mg granules for oral suspension in sachetAtnahs Pharma Netherlands B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eadcbbdb-3834-4f41-b093-ad8ae65be702 GET /v1/drugs/eadcbbdb-3834-4f41-b093-ad8ae65be702?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "granulat til oral suspension i brev",
"source": "dkma",
"strength": "60 mg",
"auth_role": "MOD",
"dk_drugid": "28106027617",
"substance": "Macimorelinacetat",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43476"
}See everything about macimorelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.